The global Radiotherapy market was valued at USD 7.1 Billion in 2024 and is forecasted to reach USD 9.9 Billion by 2033, exhibiting a CAGR of 3.8% during the period 2025-2033. The market growth is driven by rising cancer incidence, rapid technological advancements, improved tumor targeting accuracy, increased healthcare costs, and greater awareness regarding radiotherapy as a non-invasive cancer treatment. North America is currently the dominant region with a market share exceeding 35.8%.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Radiotherapy Market Key Takeaways
- Current Market Size: USD 7.1 Billion in 2024
- CAGR: 3.8%
- Forecast Period: 2025-2033
- North America leads with a market share of over 35.8% in 2024.
- The United States holds over 85% market share in North America, driven by high cancer incidence and advanced treatment technologies.
- External beam radiation therapy represents about 62.0% market share due to its efficiency and adaptability.
- Breast cancer is the leading application segment with around 28.8% market share in 2024.
- Ambulatory and radiotherapy centers dominate the end user segment due to cost-efficiency and convenience.
Sample Request Link:
https://www.imarcgroup.com/radiotherapy-market/requestsample
Market Growth Factors
The Radiotherapy Market is primarily driven by the rising global incidence of cancer and the continuous expansion of oncology treatment infrastructure. Increasing cases of breast, lung, prostate, and colorectal cancers are significantly boosting demand, positively influencing Radiotherapy Market Size and long-term adoption. Governments and private healthcare providers are investing heavily in advanced cancer care centers, particularly across emerging economies, strengthening overall Radiotherapy Market Growth. Improved access to diagnosis, early screening programs, and multidisciplinary cancer treatment approaches are further accelerating radiotherapy utilization. As survival rates improve and treatment volumes increase, the Radiotherapy Market Share continues to expand, reinforcing a strong Radiotherapy Market Forecast through 2033.
Rapid technological innovation is another major growth catalyst shaping the Radiotherapy Market Trends globally. Advanced solutions such as intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), stereotactic radiosurgery, and proton therapy are improving treatment accuracy while minimizing damage to healthy tissues. These innovations are driving upgrades and replacements in hospitals and cancer centers, strengthening the overall Radiotherapy Market Size. The integration of artificial intelligence, real-time imaging, and adaptive radiotherapy techniques is enhancing treatment planning efficiency and patient outcomes. As precision oncology becomes a standard of care, the Radiotherapy Market Growth outlook remains robust, supporting a favorable Radiotherapy Market Forecast during 2025–2033.
Increasing healthcare expenditure and supportive reimbursement frameworks are significantly contributing to the expansion of the Radiotherapy Market. Governments are prioritizing cancer treatment funding, while insurance coverage for radiotherapy procedures is improving accessibility across regions. The growing number of hospitals, specialty cancer centers, and outpatient radiotherapy facilities is strengthening the Radiotherapy Market Share across key end-user segments. Additionally, public-private partnerships and foreign investments are accelerating technology adoption in developing countries, positively impacting the radiotherapy market growth. Rising awareness about non-invasive cancer treatments and improved patient compliance further support demand, reinforcing optimistic Radiotherapy Market Trends and a stable Radiotherapy Market Forecast through 2033.
Market Segmentation
By Type:
- External Beam Radiation Therapy: Leads with around 62.0% market share in 2024 due to adaptability and precision in treating varied tumors. Advanced technologies like IMRT, SBRT, and 3D conformal radiation therapy enhance its appeal.
By Application:
- Breast Cancer: Leads with approximately 28.8% market share in 2024. It is crucial as post-operative radiotherapy prevents tumor recurrence, conserves breast tissue in early-stage cases, and controls tumor growth in metastatic stages.
By End User:
- Ambulatory and Radiotherapy Centers: Demand driven by preference for outpatient care, convenience, cost-efficiency, and technological advances making radiotherapy equipment more compact and affordable.
Regional Insights
North America dominates the radiotherapy market with a share exceeding 35.8% in 2024. This leadership stems from advanced healthcare infrastructure, robust cancer research funding, and high cancer prevalence. The United States, holding over 85% of North America's share, benefits from rapid adoption of cutting-edge radiation technologies, expansive proton therapy centers, and substantial healthcare expenditure anticipated to grow to USD 7.7 trillion by 2032. Early detection and screening programs further drive market demand.
Recent Developments & News
- October 2024: Eckert & Ziegler SE entered a global clinical supply agreement with GlyTherix Ltd for supplying GMP-grade Lutetium-177 chloride in clinical trials targeting aggressive cancers.
- August 2024: Accuray Incorporated received CE Mark approval for the Accuray Helix, a CT-guided helical radiotherapy system aimed at emerging markets, providing cost-effective, high-performance treatment.
- August 2024: Elekta announced a USD 64 Million order from Mexico's Hospital Angeles Health System for advanced linear accelerators and the Elekta Esprit Gamma Knife to enhance cancer care.
- September 2023: Siemens Healthineers acquired Aspekt to strengthen radiation oncology services.
- May 2023: General Electric Company launched new radiotherapy instruments including auto segmentation and intelligent radiation therapy (IRT) systems.
Key Players
- Accuray Incorporated
- Becton Dickinson and Company
- Eckert & Ziegler
- Elekta AB
- General Electric Company
- Hitachi Ltd
- Ion Beam Applications
- Isoray Inc.
- Mevion Medical Systems Inc.
- Nordion Inc. (Sotera Health)
- Siemens Healthineers AG (Siemens AG)
Get Custom Market Research Report for Your Business:
https://www.imarcgroup.com/request?type=report&id=4413&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302
Comments (0)